| SCHRODER ISF CHINA OPPORTUNITIES A ACC USD | RVI CHINA | 17,26% | 8,58% | -17,06% | 49,21% |
| STATE STREET EMERGING MARKETS ESG SCREENED ENHANCED EQUITY FUND I USD CAP | RVI EMERGENTES | 17,26% | 48,55% | 42,99% | · |
| TEMPLETON ASIAN GROWTH I (ACC) EUR-H1 | RVI ASIA EX-JAPÓN | 17,26% | 31,14% | -9,56% | 43,37% |
| UBS (LUX) EQUITY FUND - BIOTECH (USD) (EUR) Q-ACC | BIOTECNOLOGÍA | 17,26% | · | · | · |
| UBS (LUX) EQUITY SICAV - ALL CHINA (USD) Q-ACC | RVI CHINA | 17,26% | 17,62% | -27,27% | · |
| VANGUARD EMERGING MARKETS STOCK INDEX INSTITUTIONAL PLUS CHF CAP | RVI EMERGENTES | 17,26% | 40,57% | 30,51% | · |
| J O HAMBRO CAPITAL MANAGEMENT GLOBAL EMERGING MARKETS OPPORTUNITIES FUND A GBP | RVI EMERGENTES | 17,25% | 30,94% | 33,88% | · |
| ABRDN SICAV I-EMERGING MARKETS EQUITY FUND S ACC USD | RVI EMERGENTES | 17,24% | 25,55% | 8,13% | 45,45% |
| AB SICAV I-EUROPEAN EQUITY PORTFOLIO C EUR | RVI EUROPA | 17,24% | 31,19% | 49,52% | 54,71% |
| AMUNDI MSCI EM ASIA UCITS ETF USD CAP | RVI ASIA | 17,24% | 43,65% | 26,91% | · |
